HEARTLAND Protocol FHIR Implementation Guide
0.3.0 -
HEARTLAND Protocol FHIR Implementation Guide
0.3.0 -
HEARTLAND FHIR candidate 0.3.0 — draft, experimental R4 4.0.1 reference. Prepared for technical review; not evidence of clinical validation or vendor interoperability.
| Official URL: https://fhir.heartlandprotocol.org/ValueSet/heartland-evidence-level-vs | Version: 0.3.0 | |||
| Draft as of 2026-09-29 | Computable Name: HeartlandEvidenceLevelVS | |||
| All evidence level codes (established | emerging | pragmatic). |
References
This value set is not used here; it may be used elsewhere (e.g. specifications and/or implementations that use this content)
https://fhir.heartlandprotocol.org/CodeSystem/heartland-evidence-level version 📦0.3.0
Expansion performed internally based on codesystem HEARTLAND Evidence Level v0.3.0 (CodeSystem)
This value set contains 3 concepts
| System | Code | Display (en) | Definition | JSON | XML |
https://fhir.heartlandprotocol.org/CodeSystem/heartland-evidence-level | established | Established Evidence | Interventions with strong guideline support, such as SGLT2i for all HF phenotypes endorsed by the 2022 AHA/ACC/HFSA guideline. | ||
https://fhir.heartlandprotocol.org/CodeSystem/heartland-evidence-level | emerging | Emerging Evidence | Recent trial findings not yet fully incorporated into guidelines, such as finerenone for HFpEF based on the FINEARTS-HF trial. | ||
https://fhir.heartlandprotocol.org/CodeSystem/heartland-evidence-level | pragmatic | Pragmatic Heuristic | Tools developed for clinical utility without formal statistical validation, such as the HEARTLAND Risk Score itself. |